{"name":"Telios Pharma, Inc.","slug":"telios-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOVExJQ0tfMFJObmFMTkhzZ1FvYlFwN2VsVFN6bUQ5b3ZzOHBtd3VuUjE0Rjltc2M0emFHVG92TmRYUE1ZVmVqYW04ZVhuR1IyWHhSdXBKUGlnRnJldUdCbXUzYURucWRnbFR4SDZaajFmYXlyMUIxdmVieWRKdUtmM3RxOS1IMTgyb0V4bWt3Q1hNOXBpVmpudg?oc=5","date":"2026-03-20","type":"pipeline","source":"openPR.com","summary":"Myelofibrosis Pipeline 2026: Therapies Under Investigation, - openPR.com","headline":"Myelofibrosis Pipeline 2026: Therapies Under Investigation,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPOEJzQW5qZTRBalY2QXdJanVieVVNSngta1phZ3UtTEpRZjJMY2hJcjBiXzVGWFh4NU5hMnkySmxiUUJLSlJ6ZEpsWmlweExLY1Bma2pJQV9HTElicHhvOEU5bjM5V3IyU1h1RmNuSHVHMGlfU3JkY3E2WUFIZ3dkTDBEY0xxX04xc1dIZ2lOQWp3OWZZTWdOMU04LUVOU2NqdXFIMjAtQ3lmc1F1Q2tzNTlqTEtXVnd5R0dmTkdvekUxdkhlampENGp1eU1qcmxWRk83eFZLQVluazdvNU1uR1VZZ1dCRjFs?oc=5","date":"2025-09-03","type":"pipeline","source":"PR Newswire","summary":"Myelofibrosis Market is Going to Grow at a CAGR of 9% in the Next Ten Years (2025-2034) | DelveInsight - PR Newswire","headline":"Myelofibrosis Market is Going to Grow at a CAGR of 9% in the Next Ten Years (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQNzczWXhHaENxQ2FYNGZOakstMm5kSzl3cUlkWHdON1ZieXY3eW9aZTRaYWdKSkRvNjJuMUZCaTZNWE5ORGthUERLM2dqemczQVcyS21vb3k2b1JrR2JuaC00TnF4aWFoRDNSQTZNUUVfY2ZYQk05RXp1T3Bud3NRazdhdFBDYm1tSWE3OU9mRzFpUml3Um91N25aVEpJZlRwS2h5bV81dw?oc=5","date":"2025-05-04","type":"pipeline","source":"The Business Journals","summary":"Billionaire investor sells oceanfront home lot for $22 million - The Business Journals","headline":"Billionaire investor sells oceanfront home lot for $22 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE42Y1RZSUlzOERfZXFhZ1h0WTI1SGJjREgwUHV5c0w0SGtnT2IzTnYzSVF6RlFkbklMQWFidTZhSmItaG42Mk9ZUmFoQVdOZjBhTWs5a0lGcU1OY1M1RzdHNC1UcWwwOVdWRHc?oc=5","date":"2024-12-31","type":"pipeline","source":"Exhibitor Online","summary":"Vision Quest - Exhibitor Online","headline":"Vision Quest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBYZ1YwdTVESVZOQTNxbk4xQ0JROFktdktJWXVUaTV3ajBtZVVxUmJDVVVKMHFnR0wwNnFMYzlfVTZzd0M1SnQ0VUwyQV9pRDFtZ1BOdFJnRlc0QU9qbUc3RktuZDdsMl8yNGc?oc=5","date":"2024-12-31","type":"pipeline","source":"Exhibitor Online","summary":"EXHIBITOR Magazine's 38th Annual Exhibit Design Awards - Exhibitor Online","headline":"EXHIBITOR Magazine's 38th Annual Exhibit Design Awards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBNU1F3VVJkWmVrNjVoX0RwcGNCQW5xV0pnY1VPUGRka21ocUlzVnhkU041cWxsTlRCZ1VvN1k2YWJfWVg0cGNQb3FkTENUSF9nV2o2VE1wX0l5ektWdHAtVzNPdGxiVFA3MHR2b1VacFlmUQ?oc=5","date":"2024-06-10","type":"pipeline","source":"Hartford Courant","summary":"Harvey S. SADOW - Hartford Courant","headline":"Harvey S. SADOW","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPdlAyWjhTRldQXzhnTGctVDZYbU55c0pJOHRZWlZvUmdQR3AxdGltNkJVTDB5Xy1hVWZyOVpxdlRCcXRvd050SWZKN3BhS3lnMmEyb21RRTVKTU91OUtwY0pDOHdNalAyaGtSNUNORnFJcXFWNnNMd01wb1VyaE4xSExhaThmaENTaHNwVEI0SEk0RkJLcTVyaDVrQ3hVb3h4RGJjeDVzb21OZVo1aDNDbEhMdnJ4Zmtn?oc=5","date":"2024-03-11","type":"trial","source":"Eyes On Eyecare","summary":"Positive topline data released for Telios Pharma's DED treatment - Eyes On Eyecare","headline":"Positive topline data released for Telios Pharma's DED treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPZW81NldZdW85cTZDcG5lUWRkekNCVTlNRTdOZHRWUkxOdXVPeE50NTB2VDhRdld0R2dWdVRzLWtYNTZsS1lhcURUUXFRM0tEeEE0SjBwdWZ6ekprT0ZQbWJ6ZkMzeldMc1cyc3RjdVRUaHg4Yi1GNDl5bFBZWEhFWWZTUWpYNWlTdllkcGdlTWNQTjlLWGNFNENTeTZwUjdBcUVoeUZKeWc5YjNsbnoyWGtyZFNyS094S3RsZHBEUHVSN250U1Y2RG9HT2g2N3B0NDdLclJDem5MNUZsc1cweHY1SG42YzB2b2NPTTdyTGdidw?oc=5","date":"2024-03-07","type":"trial","source":"Ophthalmology Times","summary":"Telios Pharma announces topline results from Phase 2 trial of TL-925 in patients with moderate to severe dry eye disease - Ophthalmology Times","headline":"Telios Pharma announces topline results from Phase 2 trial of TL-925 in patients with moderate to severe dry eye disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPc1B5cnY1ZFF1d3ZlbDVKMXktQjA5WkhnN2tfS0FfRmRzbGg3cU1YRlBtYTAxNk9GN2pHbTV0YXk2cm52eGNOT2VJVzBmNnI5RUNCQnVyTUd6RmZWNG83MWxybngzSGxEUzVNdEJDVnZremNPakFqeXNBWGx0d0pwSmxTMHFGSlMzdWMxekRYWW8yV0h0MGkwdWk5WDdBaHE4c2lzMVhiSE5faUdnRXl1M2RWb29EOW9JUjczTzltSG8yVlJVZmNFTi0xcjd1NHctX21JNmEtVm1VVEVxYl9mRl82NWtxOTJMR3JDTg?oc=5","date":"2024-03-06","type":"trial","source":"Business Wire","summary":"Telios Pharma Announces Successful Phase 2 Results for TL-925, a Novel Treatment for Dry Eye Disease - Business Wire","headline":"Telios Pharma Announces Successful Phase 2 Results for TL-925, a Novel Treatment for Dry Eye Disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1QTklFMTgzVG1EV2Z5NlpkbFZ5VFJIdTljTnoxNnRYZm5qOVhibmdzU2lnaE81bDhVRUxDUzR5b05oWGtTeFY5VnV5bGcyb1lnTjE5MHBHaw?oc=5","date":"2002-12-01","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}